R. N. Weinreb and P. T. Khaw, Comparison of glaucomatous progression between untreated patients with normal-443 tension glaucoma and patients with therapeutically reduced intraocular pressures, Lancet Lond Engl, vol.363, issue.9422, 2004.

, Collaborative Normal-Tension Glaucoma Study Group, Am J Ophthalmol, 199813.

J. B. Jonas, W. Budde, A. Stroux, I. M. Oberacher-velten, and A. Jünemann, Single Intraocular 487 Pressure Measurements and Diurnal Intraocular Pressure Profiles, Am J Ophthalmol, vol.139, issue.6, p.14, 2005488-06.

B. Bengtsson, M. C. Leske, L. Hyman, and A. Heijl, Early Manifest Glaucoma Trial Group. 491 Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma 492 trial, Ophthalmology, vol.114, issue.2, p.15, 2007.

T. M. Grippo, J. Liu, N. Zebardast, T. B. Arnold, G. H. Moore et al., Twenty-495 four-hour pattern of intraocular pressure in untreated patients with ocular hypertension. Invest 496 Ophthalmol Vis Sci, vol.54, p.16, 2013.

J. Liu, X. Zhang, D. F. Kripke, and R. N. Weinreb, Twenty-four-hour intraocular pressure 499 pattern associated with early glaucomatous changes, Invest Ophthalmol Vis Sci, vol.44, issue.4, pp.1586-90, 2003500-04.

J. Caprioli and A. L. Coleman, Intraocular pressure fluctuation a risk factor for visual field 503 progression at low intraocular pressures in the advanced glaucoma intervention study

, Ophthalmology, vol.115, issue.7, p.18, 2008.

K. Mansouri and R. Weinreb, Continuous 24-hour intraocular pressure monitoring for 507 glaucoma--time for a paradigm change, Swiss Med Wkly, vol.142, p.19, 2012.

M. Leonardi, E. M. Pitchon, A. Bertsch, P. Renaud, and A. Mermoud, Wireless contact lens 510 sensor for intraocular pressure monitoring: assessment on enucleated pig eyes. Acta 511 Ophthalmol (Copenh), vol.87, pp.433-440, 2009.

K. Mansouri, F. A. Medeiros, A. Tafreshi, and R. N. Weinreb, Continuous 24-hour monitoring 514 of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and 515 reproducibility in patients with glaucoma, Arch Ophthalmol Chic Ill, vol.130, issue.12, p.21, 1960.

D. Smedt, S. Mermoud, A. Schnyder, and C. , 24-hour intraocular pressure fluctuation 519 monitoring using an ocular telemetry Sensor: tolerability and functionality in healthy subjects, 520 J Glaucoma, vol.21, issue.8, p.22, 2012.

G. E. Dunbar, B. Y. Shen, and A. A. Aref, The Sensimed Triggerfish contact lens sensor: 523 efficacy, safety, and patient perspectives, Clin Ophthalmol Auckl NZ, vol.11, p.23, 2017.

F. Aptel, R. N. Weinreb, C. Chiquet, and K. Mansouri, 24-h monitoring devices and 526 nyctohemeral rhythms of intraocular pressure, Prog Retin Eye Res, vol.55, p.24, 2016.

S. M. Ittoop, J. R. Soohoo, L. K. Seibold, K. Mansouri, and M. Y. Kahook, , p.529

, Current Devices for 24-h Intraocular Pressure Monitoring, Adv Ther, vol.33, issue.10, pp.1679-530, 2016.

K. Mansouri and R. N. Weinreb, Ambulatory 24-h intraocular pressure monitoring in the 533 management of glaucoma, Curr Opin Ophthalmol, vol.26, issue.3, pp.214-234, 2015.

A. A. Aref and D. L. Budenz, Detecting Visual Field Progression, Ophthalmology, vol.124, issue.12S, p.40, 2017587-12.

S. K. Gardiner, Differences in the Relation Between Perimetric Sensitivity and 590

G. Sunaric-megevand, P. Leuenberger, and P. Preußner, Assessment of the Triggerfish 594 contact lens sensor for measurement of intraocular pressure variations, Variability Between Locations Across the Visual Field. Invest Ophthalmol Vis Sci, vol.59, p.42, 2014.

M. Leonardi, Assessment of the 598 Triggerfish contact lens sensor for measurement of intra-ocular pressure variations, vol.94, p.43, 2016.

K. Mansouri, R. N. Weinreb, J. Liu, P. Vitish-sharma, A. G. Acheson et al., Can the 605 SENSIMED Triggerfish® lens data be used as an accurate measure of intraocular pressure? 606 Acta Ophthalmol, PloS One, vol.10, issue.5, pp.242-248, 2015.

. Références,

B. Thylefors and A. D. Négrel, The global impact of glaucoma, Bull World Health Organ, vol.72, issue.3, pp.323-329, 1994.

, Haute Autorité de Santé -Dépistage et diagnostic précoce du glaucome : problématique et perspectives en France

Y. Tham, X. Li, T. Y. Wong, H. A. Quigley, T. Aung et al., Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis, Ophthalmology, vol.121, issue.11, pp.2081-90, 2014.

H. A. Quigley and A. T. Broman, The number of people with glaucoma worldwide in 2010 and 2020, Br J Ophthalmol, vol.90, issue.3, pp.262-269, 2006.

R. N. Weinreb and P. T. Khaw, Primary open-angle glaucoma, Lancet, vol.363, issue.9422, pp.1711-1731, 2004.

L. Jones, S. R. Bryan, and D. P. Crabb, Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens, J Ophthalmol, p.1621640, 2017.

C. Stowell, C. F. Burgoyne, E. R. Tamm, and C. R. Ethier, Lasker/IRRF Initiative on Astrocytes and Glaucomatous Neurodegeneration Participants. Biomechanical aspects of axonal damage in glaucoma: A brief review, Exp Eye Res, vol.157, pp.13-22, 2017.

R. R. Allingham, Y. Liu, and D. J. Rhee, The genetics of primary open-angle glaucoma: a review, Exp Eye Res, vol.88, issue.4, pp.837-881, 2009.

S. De-voogd, M. K. Ikram, R. Wolfs, N. M. Jansonius, A. Hofman et al., Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study, Ophthalmology, vol.112, issue.9, pp.1487-93, 2005.

V. Doshi, M. Ying-lai, S. P. Azen, and R. Varma, Los Angeles Latino Eye Study Group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino Eye Study, Ophthalmology, vol.115, issue.4, pp.639-647, 2008.

M. C. Leske, A. M. Connell, S. Y. Wu, L. G. Hyman, and A. P. Schachat, Risk factors for openangle glaucoma. The Barbados Eye Study, Arch Ophthalmol, vol.113, issue.7, pp.918-942, 1995.

B. N. Mukesh, C. A. Mccarty, J. L. Rait, and H. R. Taylor, Five-year incidence of open-angle glaucoma: the visual impairment project, Ophthalmology, vol.109, issue.6, pp.1047-51, 2002.

, The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators, Am J Ophthalmol, vol.130, issue.4, pp.429-469, 2000.

M. C. Leske, A. Heijl, L. Hyman, B. Bengtsson, and E. Komaroff, Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial, Curr Opin Ophthalmol, vol.15, issue.2, pp.102-108, 2004.

H. A. Quigley, G. R. Dunkelberger, and W. R. Green, Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma, Am J Ophthalmol, vol.107, issue.5, pp.453-64, 1989.

H. A. Quigley, J. Katz, R. J. Derick, D. Gilbert, and A. Sommer, An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage, Ophthalmology, vol.99, issue.1, pp.19-28, 1992.

, Terminology and guidelines for glaucoma, 2014.

R. F. Brubaker, Flow of aqueous humor in humans

, Invest Ophthalmol Vis Sci, vol.32, issue.13, pp.3145-66, 1991.

B. Mottet, C. Chiquet, F. Aptel, C. Noel, C. Gronfier et al., 24-hour intraocular pressure of young healthy humans in supine position: rhythm and reproducibility, Invest Ophthalmol Vis Sci, vol.53, issue.13, pp.8186-91, 2012.

F. Aptel, R. N. Weinreb, C. Chiquet, and K. Mansouri, 24-h monitoring devices and nyctohemeral rhythms of intraocular pressure, Prog Retin Eye Res, vol.55, pp.108-156, 2016.

J. Caprioli and A. L. Coleman, Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study, Ophthalmology, vol.115, issue.7, pp.1123-1132, 2008.

S. M. Ittoop, J. R. Soohoo, L. K. Seibold, K. Mansouri, and M. Y. Kahook, Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring, Adv Ther, vol.33, issue.10, pp.1679-90, 2016.

Y. Barkana, S. Anis, J. Liebmann, C. Tello, and R. R. , Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma, Arch Ophthalmol, vol.124, issue.6, pp.793-800, 2006.

T. M. Grippo, J. Liu, N. Zebardast, T. B. Arnold, G. H. Moore et al., Twentyfour-hour pattern of intraocular pressure in untreated patients with ocular hypertension, Invest Ophthalmol Vis Sci, vol.54, issue.1, pp.512-519, 2013.

M. Leonardi, E. M. Pitchon, A. Bertsch, P. Renaud, and A. Mermoud, Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes, Acta Ophthalmol, vol.87, issue.4, pp.433-440, 2009.

M. Leonardi, P. Leuenberger, D. Bertrand, A. Bertsch, and P. Renaud, First steps toward noninvasive intraocular pressure monitoring with a sensing contact lens, Invest Ophthalmol Vis Sci, vol.45, issue.9, pp.3113-3120, 2004.

K. Mansouri and R. Weinreb, Continuous 24-hour intraocular pressure monitoring for glaucoma--time for a paradigm change, Swiss Med Wkly, vol.142, p.13545, 2012.

M. A. Kass, D. K. Heuer, E. J. Higginbotham, C. A. Johnson, J. L. Keltner et al., The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch Ophthalmol, vol.120, issue.6, pp.701-714, 2002.

K. Mansouri, F. A. Medeiros, A. Tafreshi, and R. N. Weinreb, Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma, Arch Ophthalmol, vol.130, issue.12, pp.1534-1543, 2012.

K. Mansouri, R. N. Weinreb, and J. Liu, Efficacy of a contact lens sensor for monitoring 24-h intraocular pressure related patterns, PLoS ONE, vol.10, issue.5, p.125530, 2015.

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, J'informerai les patients des décisions envisagées, de leurs raisons et de leurs

, Admis(e) dans l'intimité des personnes, je tairai les secrets qui me seront confiés

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses